These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2926240)

  • 21. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
    Manninen V; Tenkanen L; Koskinen P; Huttunen JK; Mänttäri M; Heinonen OP; Frick MH
    Circulation; 1992 Jan; 85(1):37-45. PubMed ID: 1728471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary and familial hypoalphalipoproteinemia.
    Third JL; Montag J; Flynn M; Freidel J; Laskarzewski P; Glueck CJ
    Metabolism; 1984 Feb; 33(2):136-46. PubMed ID: 6694557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol guidelines, lipoprotein cholesterol levels, and triglyceride levels: potential for misclassification of coronary heart disease risk.
    Laemmle P; Unger L; McCray C; Chalin M; Glueck CJ
    J Lab Clin Med; 1989 Mar; 113(3):325-34. PubMed ID: 2926240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial lipoprotein disorders and premature coronary artery disease.
    Schaefer EJ; Genest JJ; Ordovas JM; Salem DN; Wilson PW
    Atherosclerosis; 1994 Aug; 108 Suppl():S41-54. PubMed ID: 7802728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.
    Frost PH; Havel RJ
    Am J Cardiol; 1998 Feb; 81(4A):26B-31B. PubMed ID: 9526810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triglyceride, high density lipoprotein, and coronary heart disease.
    Consens Statement; 1992 Feb 26-28; 10(2):1-28. PubMed ID: 1286136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. At what levels of total low- or high-density lipoprotein cholesterol should diet/drug therapy be initiated? United States guidelines.
    LaRosa JC
    Am J Cardiol; 1990 Mar; 65(12):7F-10F. PubMed ID: 2180270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-density lipoprotein, low-density lipoprotein and coronary artery disease.
    Wilson PW
    Am J Cardiol; 1990 Sep; 66(6):7A-10A. PubMed ID: 2203248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and evaluation of dyslipoproteinemia.
    Cleeman JI
    Endocrinol Metab Clin North Am; 1998 Sep; 27(3):597-611, ix. PubMed ID: 9785055
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.